Dimerix Ltd
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology. The company is… Read more
Market Cap & Net Worth: Dimerix Ltd (SBMJF)
Dimerix Ltd (PINK:SBMJF) has a market capitalization of $150.10 Million ($150.10 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #17535 globally and #6640 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dimerix Ltd's stock price $0.25 by its total outstanding shares 600396776 (600.40 Million).
Dimerix Ltd Market Cap History: 2015 to 2025
Dimerix Ltd's market capitalization history from 2015 to 2025. Data shows growth from $1.20 Million to $150.10 Million (66.54% CAGR).
Dimerix Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dimerix Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
26.87x
Dimerix Ltd's market cap is 26.87 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $159.11 Million | $407.47K | -$17.08 Million | 390.47x | N/A |
| 2025 | $150.10 Million | $5.59 Million | -$13.25 Million | 26.87x | N/A |
Competitor Companies of SBMJF by Market Capitalization
Companies near Dimerix Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Dimerix Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Dimerix Ltd Historical Marketcap From 2015 to 2025
Between 2015 and today, Dimerix Ltd's market cap moved from $1.20 Million to $ 150.10 Million, with a yearly change of 66.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $150.10 Million | -5.66% |
| 2024 | $159.11 Million | +13150.00% |
| 2023 | $1.20 Million | 0.00% |
| 2022 | $1.20 Million | 0.00% |
| 2021 | $1.20 Million | 0.00% |
| 2020 | $1.20 Million | 0.00% |
| 2019 | $1.20 Million | 0.00% |
| 2018 | $1.20 Million | 0.00% |
| 2017 | $1.20 Million | 0.00% |
| 2016 | $1.20 Million | 0.00% |
| 2015 | $1.20 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Dimerix Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $150.10 Million USD |
| MoneyControl | $150.10 Million USD |
| MarketWatch | $150.10 Million USD |
| marketcap.company | $150.10 Million USD |
| Reuters | $150.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.